Case Study: Regeneron, Sanofi’s Dupilumab Development to approval
The U.S. Food and Drug Administration on Tuesday approved Regeneron Pharmaceuticals Inc and Sanofi SA’s drug for moderate-to-severe atopic dermatitis. Bio-molecule: Dupilumab... Read More